EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for KOD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -1.048
March 31, 2026 -0.9402
December 31, 2025 -1.042
September 30, 2025 -1.163
June 30, 2025 -1.029
March 31, 2025 -1.089
December 31, 2024 -0.8377
September 30, 2024 -0.8352
June 30, 2024 -0.8585
March 31, 2024 -0.8196
December 31, 2023 -1.134
September 30, 2023 -0.9533
June 30, 2023 -1.531
March 31, 2023 -1.352
December 31, 2022 -1.347
September 30, 2022 -1.473
June 30, 2022 -1.736
March 31, 2022 -1.834
Date Value
December 31, 2021 -1.792
September 30, 2021 -1.302
June 30, 2021 -1.083
March 31, 2021 -0.9782
December 31, 2020 -0.9698
September 30, 2020 -0.8006
June 30, 2020 -0.5781
March 31, 2020 -0.5442
December 31, 2019 -0.3951
September 30, 2019 -0.3316
June 30, 2019 -0.3053
March 31, 2019 -0.2144
December 31, 2018 -0.3981
September 30, 2018 -0.2838
March 31, 2018 -0.2422
December 31, 2017 -0.3151
September 30, 2017 -0.1244

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics